Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RBR-39z9pbPhase 3Not yet recruiting
Phase 3, open-label trial of levobupivacaine in Leg fracture, Foot fracture, ankle fracture and 2 more (2 arms), sponsored by Centro Universitário Faculdade de Medicina do ABC. Planned start Jul 2015; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on RBR-39z9pb.